
AlloVir ALVR
AlloVir EV/EBITDA | ALVR
EV/EBITDA Jährlich AlloVir
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.19 | -1.32 | 0.208 | -2.48 | -3.96 | -17.3 | - | - | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.19 | -17.3 | -3.95 |
EV/EBITDA anderer Aktien in der Pharmaeinzelhändler
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Zai Lab Limited
ZLAB
|
-99.8 | $ 21.01 | -4.16 % | $ 23 B | ||
|
Neos Therapeutics, Inc.
NEOS
|
-17.5 | - | -2.54 % | $ 57.2 M | ||
|
Zentalis Pharmaceuticals
ZNTL
|
-1.5 | $ 1.37 | 0.74 % | $ 98.5 M | ||
|
Zoetis
ZTS
|
135 | $ 78.81 | -2.47 % | $ 34.9 B | ||
|
Odonate Therapeutics, Inc.
ODT
|
-4.74 | - | -3.18 % | $ 58.5 M | ||
|
Orphazyme A/S
ORPH
|
0.718 | - | -2.25 % | $ 31.3 M | ||
|
Osmotica Pharmaceuticals plc
OSMT
|
16.1 | - | -10.74 % | $ 89.9 M | ||
|
Pandion Therapeutics, Inc.
PAND
|
-11.2 | - | - | $ 1.77 B | ||
|
Xenetic Biosciences
XBIO
|
0.897 | $ 1.47 | -4.55 % | $ 2.5 M | ||
|
Translate Bio, Inc.
TBIO
|
350 | - | - | $ 2.81 B | ||
|
Trillium Therapeutics Inc.
TRIL
|
-14 | - | - | $ 1.94 B | ||
|
Urovant Sciences Ltd.
UROV
|
-1.91 K | - | - | $ 532 M | ||
|
Acceleron Pharma Inc.
XLRN
|
-47 | - | - | $ 10.9 B | ||
|
Zogenix, Inc.
ZGNX
|
-4.47 | - | -4.97 % | $ 664 M | ||
|
Yunhong International
ZGYH
|
44 | - | 0.10 % | $ 92.2 M | ||
|
ZIOPHARM Oncology, Inc.
ZIOP
|
-8.58 | - | -7.58 % | $ 264 M | ||
|
Taysha Gene Therapies
TSHA
|
-11.3 | $ 3.71 | -1.72 % | $ 1.19 B | ||
|
Vericel Corporation
VCEL
|
84.9 | $ 57.41 | -1.46 % | $ 2.89 B | ||
|
Vir Biotechnology
VIR
|
-2.19 | $ 8.37 | -5.64 % | $ 1.16 B | ||
|
Veracyte
VCYT
|
35.1 | $ 25.08 | 0.16 % | $ 1.97 B | ||
|
Viking Therapeutics
VKTX
|
-7.87 | $ 24.72 | -4.35 % | $ 2.79 B | ||
|
Vanda Pharmaceuticals
VNDA
|
-2.9 | $ 3.44 | -6.27 % | $ 203 M | ||
|
VistaGen Therapeutics
VTGN
|
-0.055 | $ 0.16 | -12.33 % | $ 6.09 M | ||
|
Voyager Therapeutics
VYGR
|
-1.82 | $ 1.52 | -5.9 % | $ 89.2 M | ||
|
Verrica Pharmaceuticals
VRCA
|
-4.89 | $ 2.74 | -5.03 % | $ 29.2 M | ||
|
Wave Life Sciences Ltd.
WVE
|
-9.94 | $ 2.56 | -6.07 % | $ 432 M | ||
|
XBiotech
XBIT
|
0.841 | $ 1.75 | 4.17 % | $ 53.4 M | ||
|
XTL Biopharmaceuticals Ltd.
XTLB
|
-396 | $ 1.37 | -7.43 % | $ 922 M | ||
|
Adial Pharmaceuticals
ADIL
|
0.407 | $ 3.15 | -35.42 % | $ 2.11 M | ||
|
ADMA Biologics
ADMA
|
19.2 | $ 13.18 | -1.2 % | $ 3.14 B | ||
|
Exicure
XCUR
|
-8.87 | $ 0.96 | -7.24 % | $ 6.05 M | ||
|
Xencor
XNCR
|
-6.45 | $ 33.48 | -1.56 % | $ 2.49 B | ||
|
Cortexyme
CRTX
|
-2.13 | - | -1.05 % | $ 67.1 M | ||
|
Burford Capital Limited
BUR
|
24.7 | $ 3.24 | -5.55 % | $ 710 M | ||
|
Daré Bioscience
DARE
|
-1.83 | $ 0.41 | -9.93 % | $ 4.58 M | ||
|
Fate Therapeutics
FATE
|
-1.04 | $ 0.92 | -9.07 % | $ 109 M | ||
|
Greenwich LifeSciences
GLSI
|
-19.8 | $ 19.09 | -3.54 % | $ 258 M | ||
|
Halozyme Therapeutics
HALO
|
25 | $ 91.28 | -1.89 % | $ 10.9 B | ||
|
Hutchison China MediTech Limited
HCM
|
-481 | $ 13.18 | -2.04 % | $ 11.3 B | ||
|
Aptorum Group Limited
APM
|
29.7 | - | - | $ 5.72 M | ||
|
iBio
IBIO
|
-2.85 | $ 0.83 | 3.01 % | $ 86.4 M | ||
|
Kodiak Sciences
KOD
|
-9.31 | $ 97.05 | -0.87 % | $ 5.16 B | ||
|
Karyopharm Therapeutics
KPTI
|
-3.77 | $ 0.02 | -56.5 % | $ 219 | ||
|
FSD Pharma
HUGE
|
-0.271 | - | 5743.5 % | $ 69.7 M | ||
|
BioAtla
BCAB
|
144 | $ 1.74 | 0.64 % | $ 102 M | ||
|
Catalyst Pharmaceuticals
CPRX
|
9.61 | - | - | $ 3.85 B | ||
|
UroGen Pharma Ltd.
URGN
|
-8.98 | $ 28.91 | -8.89 % | $ 1.39 B | ||
|
Catalyst Biosciences
CBIO
|
70.6 | $ 13.01 | 0.74 % | $ 1.16 B | ||
|
ARCA biopharma
ABIO
|
0.248 | - | 1052.0 % | $ 415 M | ||
|
ADiTx Therapeutics
ADTX
|
-0.487 | - | - | $ 374 |